NICU Fundamental Analysis - MAGNA MINING INC

Fundamental Rating

Taking everything into account, NICU scores 4 out of 10 in our fundamental rating. NICU was compared to 804 industry peers in the Metals & Mining industry. While NICU seems to be doing ok healthwise, there are quite some concerns on its profitability. NICU is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

NICU had positive earnings in the past year.

In the past year NICU has reported a negative cash flow from operations.

In the past 5 years NICU always reported negative net income.

In the past 5 years NICU always reported negative operating cash flow.

1.2 Ratios

NICU has a Return On Assets of 10.71%. This is amongst the best in the industry. NICU outperforms 93.16% of its industry peers.

The Return On Equity of NICU (12.09%) is better than 91.42% of its industry peers.

		Industry Rank	Sector Rank
ROA	10.71%
ROE	12.09%
ROIC	N/A

ROA(3y)-53.61%

ROA(5y)N/A

ROE(3y)-65.13%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NICU has a better Profit Margin (10.81%) than 91.92% of its industry peers.

The Operating Margin and Gross Margin are not available for NICU so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	10.81%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NICU has more shares outstanding than it did 1 year ago.

NICU has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, NICU has an improved debt to assets ratio.

2.2 Solvency

NICU has an Altman-Z score of 93.51. This indicates that NICU is financially healthy and has little risk of bankruptcy at the moment.

NICU's Altman-Z score of 93.51 is amongst the best of the industry. NICU outperforms 89.30% of its industry peers.

A Debt/Equity ratio of 0.00 indicates that NICU is not too dependend on debt financing.

NICU has a Debt to Equity ratio (0.00) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	93.51

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 5.77 indicates that NICU has no problem at all paying its short term obligations.

NICU has a Current ratio of 5.77. This is in the better half of the industry: NICU outperforms 74.50% of its industry peers.

A Quick Ratio of 5.77 indicates that NICU has no problem at all paying its short term obligations.

The Quick ratio of NICU (5.77) is better than 74.75% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.77
Quick Ratio	5.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 129.05% over the past year.

EPS 1Y (TTM)129.05%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-89.47%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

NICU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 109.05% yearly.

NICU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 166.02% yearly.

EPS Next Y530%

EPS Next 2Y61.25%

EPS Next 3Y223.48%

EPS Next 5Y109.05%

Revenue Next Year889.23%

Revenue Next 2Y338.7%

Revenue Next 3Y298.55%

Revenue Next 5Y166.02%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 145.00, the valuation of NICU can be described as expensive.

85.57% of the companies in the same industry are more expensive than NICU, based on the Price/Earnings ratio.

NICU is valuated expensively when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.

Based on the Price/Forward Earnings ratio of 239.27, the valuation of NICU can be described as expensive.

Based on the Price/Forward Earnings ratio, NICU is valued cheaply inside the industry as 85.45% of the companies are valued more expensively.

NICU is valuated expensively when we compare the Price/Forward Earnings ratio to 23.40, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	145
Fwd PE	239.27

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as NICU's earnings are expected to grow with 223.48% in the coming years.

PEG (NY)0.27

PEG (5Y)N/A

EPS Next 2Y61.25%

EPS Next 3Y223.48%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NICU does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

MAGNA MINING INC

TSX-V:NICU (12/29/2025, 7:00:00 PM)

2.9

-0.07 (-2.36%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryMetals & Mining

Earnings (Last)11-25 2025-11-25/amc

Earnings (Next)04-07 2026-04-07

Inst Owners13.69%

Inst Owner ChangeN/A

Ins Owners7.08%

Ins Owner ChangeN/A

Market Cap724.25M

Revenue(TTM)39.20M

Net Income(TTM)4.24M

Analysts82.5

Price Target4.12 (42.07%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)1.89%

PT rev (3m)9.49%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)227.41%

EPS NY rev (3m)249.57%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)2.88%

Revenue NY rev (3m)-9.44%

Valuation

		Industry Rank	Sector Rank
PE	145
Fwd PE	239.27
P/S	18.48
P/FCF	N/A
P/OCF	N/A
P/B	20.67
P/tB	20.67
EV/EBITDA	N/A

EPS(TTM)0.02

EY0.69%

EPS(NY)0.01

Fwd EY0.42%

FCF(TTM)-0.17

FCFYN/A

OCF(TTM)-0.13

OCFYN/A

SpS0.16

BVpS0.14

TBVpS0.14

PEG (NY)0.27

PEG (5Y)N/A

Graham Number0.25

Profitability

		Industry Rank	Sector Rank
ROA	10.71%
ROE	12.09%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	10.81%
GM	N/A
FCFM	N/A

ROA(3y)-53.61%

ROA(5y)N/A

ROE(3y)-65.13%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0.99

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	153.84%
Cap/Sales	28.89%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	5.77
Quick Ratio	5.77
Altman-Z	93.51

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)86.02%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)129.05%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-89.47%

EPS Next Y530%

EPS Next 2Y61.25%

EPS Next 3Y223.48%

EPS Next 5Y109.05%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year889.23%

Revenue Next 2Y338.7%

Revenue Next 3Y298.55%

Revenue Next 5Y166.02%

EBIT growth 1Y-93.67%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-16.78%

EBIT Next 3Y130.59%

EBIT Next 5Y75.23%

FCF growth 1Y-80.45%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-33.73%

OCF growth 3YN/A

OCF growth 5YN/A

MAGNA MINING INC / NICU.CA FAQ

Can you provide the ChartMill fundamental rating for MAGNA MINING INC?

ChartMill assigns a fundamental rating of 4 / 10 to NICU.CA.

What is the valuation status of MAGNA MINING INC (NICU.CA) stock?

ChartMill assigns a valuation rating of 4 / 10 to MAGNA MINING INC (NICU.CA). This can be considered as Fairly Valued.

What is the profitability of NICU stock?

MAGNA MINING INC (NICU.CA) has a profitability rating of 3 / 10.

What is the valuation of MAGNA MINING INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MAGNA MINING INC (NICU.CA) is 145 and the Price/Book (PB) ratio is 20.67.

MAGNA MINING INC (NICU.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MAGNA MINING INC / NICU.CA FAQ

Can you provide the ChartMill fundamental rating for MAGNA MINING INC?

What is the valuation status of MAGNA MINING INC (NICU.CA) stock?

What is the profitability of NICU stock?

What is the valuation of MAGNA MINING INC based on its PE and PB ratios?